![Liang Zhao](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Liang Zhao
Direttore/Membro del Consiglio presso Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
Posizioni attive di Liang Zhao
Società | Posizione | Inizio | Fine |
---|---|---|---|
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
![]() Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Liang Zhao
Statistiche
Distribuzione geografica
Cina | 2 |
Posizioni
Director/Board Member | 1 |
Settori
Process Industries | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
![]() Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. Chemicals: Major DiversifiedProcess Industries Part of Grand Pharmaceutical Group Ltd., Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd. engages in the production and operation of amino acid API products. The company is based in Enshi, China. The Chinese company was founded in 1997. The CEO is Cheng Ping Cai. Hubei Bafeng Pharmaceuticals & Chemicals Share Co. was acquired by Grand Pharmaceutical Group Ltd. on September 27, 2022 for $39.99 million. | Process Industries |
- Borsa valori
- Insiders
- Liang Zhao
- Esperienza